BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17446857)

  • 1. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.
    Liby KT; Yore MM; Sporn MB
    Nat Rev Cancer; 2007 May; 7(5):357-69. PubMed ID: 17446857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of "rexinoids" in cancer prevention and treatment.
    Tanaka T; De Luca LM
    Cancer Res; 2009 Jun; 69(12):4945-7. PubMed ID: 19509234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer chemopreventive activity of lupane- and oleanane-type triterpenoids from the cones of Liquidamber styraciflua.
    Fukuda Y; Sakai K; Matsunaga S; Tokuda H; Tanaka R
    Chem Biodivers; 2005 Mar; 2(3):421-8. PubMed ID: 17191990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the taraxerane-oleanane rearrangement to the synthesis of seco-oleanane triterpenoids from taraxerone.
    Giang PM; Minh Trang V; Son PT; Matsunami K
    Nat Prod Res; 2015; 29(1):64-9. PubMed ID: 25219952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
    Deeb D; Gao X; Dulchavsky SA; Gautam SC
    J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals.
    Kundu JK; Surh YJ
    Mutat Res; 2005 Dec; 591(1-2):123-46. PubMed ID: 16102784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice.
    Liby K; Risingsong R; Royce DB; Williams CR; Ma T; Yore MM; Sporn MB
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1050-8. PubMed ID: 19952361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
    Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
    Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer chemopreventive activity of oleanane-type triterpenoids from the stem bark of Betula ermanii.
    Yamaguchi C; In Y; Wada S; Yamada T; Tokuda H; Tanaka R
    Chem Biodivers; 2009 Jul; 6(7):1093-100. PubMed ID: 19623559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin: the story so far.
    Sharma RA; Gescher AJ; Steward WP
    Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taming the PI3K team to hold inflammation and cancer at bay.
    Hirsch E; Ciraolo E; Ghigo A; Costa C
    Pharmacol Ther; 2008 May; 118(2):192-205. PubMed ID: 18420279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
    Krishnan AV; Feldman D
    Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac glycosides as novel cancer therapeutic agents.
    Newman RA; Yang P; Pawlus AD; Block KI
    Mol Interv; 2008 Feb; 8(1):36-49. PubMed ID: 18332483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanane-type isomeric triterpenoids from Barringtonia racemosa.
    Gowri PM; Radhakrishnan SV; Basha SJ; Sarma AV; Rao JM
    J Nat Prod; 2009 Apr; 72(4):791-5. PubMed ID: 19388709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.
    Sutherland TE; Anderson RL; Hughes RA; Altmann E; Schuliga M; Ziogas J; Stewart AG
    Drug Discov Today; 2007 Jul; 12(13-14):577-84. PubMed ID: 17631253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
    Ramos S
    Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triterpenoids for cancer prevention and treatment: current status and future prospects.
    Patlolla JM; Rao CV
    Curr Pharm Biotechnol; 2012 Jan; 13(1):147-55. PubMed ID: 21466427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.
    Liby KT; Sporn MB
    Pharmacol Rev; 2012 Oct; 64(4):972-1003. PubMed ID: 22966038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy.
    Žiberna L; Šamec D; Mocan A; Nabavi SF; Bishayee A; Farooqi AA; Sureda A; Nabavi SM
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28300756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.